Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Past 24 hours
Any time
Past hour
Past 7 days
Past 30 days
Most recent
Best match
24/7 Wall St
6h
Novo Nordisk A/S (NVO) Price Prediction and Forecast 2025-2030
When it comes to weight loss drugs, Ozempic has become a phenomenon. With nearly $14 billion in sales in 2023, it shows no ...
Managed Healthcare Executive
9h
IBX Excludes Coverage of Drugs with Accelerated Approvals for 18 Months
Independence Blue Cross has begun excluding coverage for 18 months for therapies — but not cancer drugs — that have an ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Court rejects latest attempt
Meta drops fact-checking
Finalize their divorce
Announces $20B investment
Driver pleads not guilty
Inmates reject clemency
Pleads not guilty
Sanctioned for corruption?
Biden signs RFK Stadium bill
Antisemitic threats arrest
Bodies found in landing gear
Tesla faces US probe
To roll back diversity goals
On China's cyber activity
Job openings rise
Folk legend Yarrow dies
Detainees moved to Oman
Online holiday sales rise
Files motion to dismiss case
Strong earthquake hits Tibet
US trade deficit widens
French far-right leader dies
Police reform deal approved
SoCal windstorm warning
Labels Chinese firms
Remains arrive in D.C.
Israeli raids in West Bank
To lay off 4% of staff
Draws 10.1 million viewers
Titans fire GM Carthon
CFPB rules on medical debt
Related topics
Novo Nordisk
Liraglutide
Food and Drug Administration
Feedback